We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-18.86%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$94.9M
AUM Growth
-$11.6B
Cap. Flow
+$352M
Cap. Flow %
370.94%
Top 10 Hldgs %
49.64%
Holding
849
New
169
Increased
282
Reduced
215
Closed
183

Top Buys

Rank Stock Value
1
PAA icon
Plains All American Pipeline
PAA
+$71.8M
2
BX icon
Blackstone
BX
+$60.2M
3
EEP
Enbridge Energy Partners
EEP
+$60.1M
4
BN icon
Brookfield
BN
+$55.9M
5
WPZ
Williams Partners L.P.
WPZ
+$53.2M

Top Sells

Rank Stock Value
1
CMLP
CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE)
CMLP
+$122M
2
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$25.2M
3
NE
Noble Corporation
NE
+$23.5M
4
RIG icon
Transocean
RIG
+$22.7M
5
MMP
Magellan Midstream Partners, L.P.
MMP
+$21.8M

Sector Composition

Rank Sector Weight
1 Energy 67.78%
2 Healthcare 2.32%
3 Materials 2.09%
4 Financials 1.64%
5 Consumer Discretionary 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASRT
176
DELISTED
Assertio
ASRT
$17.8K 0.02%
1,573
+582
+59% +$993K
SCMP
177
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$17.8K 0.02%
89,506
+14,322
+19% +$328K
ACOR
178
DELISTED
Acorda Therapeutics
ACOR
$17.8K 0.02%
559
+205
+58% +$795K
PDLI
179
DELISTED
PDL BioPharma, Inc.
PDLI
$17.6K 0.02%
349,936
+114,217
+48% +$654K
EBS icon
180
Emergent Biosolutions
EBS
$375M
$17.3K 0.02%
60,732
+22,701
+60% +$748K
SSRI
181
DELISTED
Silver Standard Resources
SSRI
$17.3K 0.02%
265,264
-114,272
-30% -$696K
FWP
182
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$17.2K 0.02%
10,401
+3,809
+58% +$801K
CLDX icon
183
Celldex Therapeutics
CLDX
$2.77B
$16.2K 0.02%
10,276
+3,761
+58% +$1.06M
ONCE
184
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$16K 0.02%
38,415
+14,086
+58% +$735K
HST icon
185
Host Hotels & Resorts
HST
$16.8B
$15.2K 0.02%
95,943
+600
+0.6% +$11.2K
ENTA icon
186
Enanta Pharmaceuticals
ENTA
$372M
$14.9K 0.02%
41,174
+7,326
+22% +$315K
MACK
187
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$14.7K 0.02%
21,889
+8,008
+58% +$654K
TRGP icon
188
Targa Resources
TRGP
$60.4B
$14.6K 0.02%
28,320
-7,101
-20% -$520K
PTCT icon
189
PTC Therapeutics
PTCT
$6.37B
$14.3K 0.02%
53,643
+20,052
+60% +$858K
ARES icon
190
Ares Management
ARES
$28.5B
$14.2K 0.02%
+813,394
New +$14.9M
SUPN icon
191
Supernus Pharmaceuticals
SUPN
$2.68B
$14.1K 0.01%
100,560
+53,170
+112% +$989K
ATRA icon
192
Atara Biotherapeutics
ATRA
$71.2M
$13.9K 0.01%
1,774
+808
+84% +$985K
O icon
193
Realty Income
O
$61.2B
$13.9K 0.01%
30,344
+1,239
+4% +$55.9K
SLG icon
194
SL Green Realty
SLG
$3.88B
$13.7K 0.01%
13,081
+310
+2% +$33.3K
MAC icon
195
Macerich
MAC
$7.32B
$13.7K 0.01%
17,769
+200
+1% +$15.5K
LRMR icon
196
Larimar Therapeutics
LRMR
$416M
$13.6K 0.01%
3,535
+1,312
+59% +$592K
INVA icon
197
Innoviva
INVA
$1.58B
$13.2K 0.01%
183,337
+67,360
+58% +$915K
HL icon
198
Hecla Mining
HL
$10.2B
$13K 0.01%
661,770
+200,293
+43% +$426K
IMGN
199
DELISTED
Immunogen Inc
IMGN
$12.9K 0.01%
134,900
+49,364
+58% +$722K
XLRN
200
DELISTED
Acceleron Pharma
XLRN
$12.9K 0.01%
51,747
+19,188
+59% +$577K
6 7
8
9 10

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, ALPS Advisors held 849 positions worth $94.9M, down 99% from $11.7B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

ALPS Advisors deployed $352M of net new capital in Q3 2015, opening 169 new positions and adding to 282 existing holdings. Its largest new stake was Brookfield: 4,795,507 shares worth $52.9K.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Magellan Midstream Partners, L.P., an estimated $21.8M trimmed.

  • ALPS Advisors's largest Q3 2015 buy was Brookfield: 4,795,507 shares worth $52.9K.
  • ALPS Advisors added most to Plains All American Pipeline in Q3 2015, an estimated $71.8M increase.
  • ALPS Advisors's biggest Q3 2015 reduction was Magellan Midstream Partners, L.P., cutting an estimated $21.8M.
  • ALPS Advisors fully exited CRESTWOOD MIDSTREAM PARTNERS LP NEW UTS REP LTD PRT INT (DE) in Q3 2015, selling an estimated $122M.
  • ALPS Advisors's ten largest holdings make up 50% of its $94.9M portfolio in Q3 2015.
  • ALPS Advisors opened 169 new positions and closed 183 in Q3 2015.
  • ALPS Advisors's portfolio value fell 99% quarter-over-quarter to $94.9M.

Based on ALPS Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.